The following represents disclosure information provided by authors of this abstract. The Genitourinary Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Efficacy of combined androgen blockade with zoledronic acid treatment in prostate cancer with bone metastasis: The Zoledronic Acid/Androgen Blockade Trial on Prostate Cancer (Zabton-PC) study.
Satoru Ueno
No relevant relationships to disclose
Atsushi Mizokami
No relevant relationships to disclose
Takashi Fukagai
No relevant relationships to disclose
Naohiro Fujimoto
No relevant relationships to disclose
Hitoshi Ohoka
No relevant relationships to disclose
Yukihiro Kondo
No relevant relationships to disclose
Gaku Arai
No relevant relationships to disclose
Hisamitsu Ide
No relevant relationships to disclose
Mikio Namiki
No relevant relationships to disclose